Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07283289

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

Prospective Observational Cohort Study on the Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
295 (estimated)
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Obstructive sleep apnea syndrome (OSAS) is characterized by partial (hypopnea) or complete (apnea) obstruction of the upper airways, leading to intermittent hypoxemia and sleep fragmentation. Peripheral arterial occlusive disease (PAOD) is a chronic condition defined by the narrowing or occlusion of arteries in the lower limbs, often resulting in ischemia of downstream tissues. This disease is a common complication of atherosclerosis and affects approximately 1.2% of the general French population. OSAS is a well-established risk factor for atherosclerotic disease, particularly for coronary and neurovascular events. Although a relationship between OSAS and PAOD has been investigated in recent years, the link has not been definitively established and requires further study. Therefore, this preliminary cohort study aims to observe the prevalence of OSAS among patients diagnosed with PAOD, regardless of the disease stage.

Conditions

Timeline

Start date
2025-11-05
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2025-12-15
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07283289. Inclusion in this directory is not an endorsement.